Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 05, 2020

SELL
$0.96 - $2.94 $62,400 - $191,100
-65,000 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$2.56 - $4.48 $51,200 - $89,600
20,000 Added 44.44%
65,000 $171,000
Q3 2018

Nov 08, 2018

BUY
$5.36 - $7.83 $53,600 - $78,300
10,000 Added 28.57%
45,000 $335,000
Q2 2018

Aug 08, 2018

BUY
$5.97 - $9.58 $29,850 - $47,900
5,000 Added 16.67%
35,000 $271,000
Q3 2017

Nov 02, 2017

BUY
$3.9 - $6.78 $39,000 - $67,800
10,000 Added 50.0%
30,000 $126,000
Q2 2017

May 14, 2018

BUY
N/A
20,000
20,000 $64,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $15.9M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.